Press Releases

NeuBase to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Sep 15, 2021 4:05pm EDT

NeuBase Therapeutics Appoints Anthony Rossomando, Ph.D. as Chief Technology Officer

Sep 14, 2021 8:00am EDT

NeuBase Therapeutics to Present Virtually at the H.C. Wainwright 23rd Annual Global Investment Conference

Sep 01, 2021 4:05pm EDT

NeuBase Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2021 and Recent Operating Highlights

Aug 12, 2021 4:01pm EDT

NeuBase Therapeutics Demonstrates Functional Rescue in Myotonic Dystrophy Type 1 Model and Allele-Selective Inhibition of KRAS Mutations to Inhibit Tumor Growth

Jun 08, 2021 12:30pm EDT

NeuBase Therapeutics Announces Speakers for Virtual R&D Day Taking Place on June 8th

Jun 02, 2021 9:00am EDT

NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer

May 25, 2021 8:00am EDT

NeuBase Therapeutics Appoints Dr. Sandra Rojas-Caro Chief Medical Officer

May 20, 2021 8:00am EDT

NeuBase Therapeutics to Participate in Upcoming Investor Conferences in May 2021

May 14, 2021 12:30pm EDT

NeuBase Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2021

May 13, 2021 4:05pm EDT

1
2
3
4
5
6
7